NEW&EVENTS

Long-acting prostaglandin implant creating shift in IOP-lowering therapy 2020-10-20

This article was reviewed by Savak Teymoorian, MD, MBA Early experience with the new intracameral bimatoprost 10-μg implant (Durysta, Allergan) in clinical practice indicates that it is a valuable addition for treating patients with ocular hypertension and ..

2019 CPHI India,India Expo Centre,26-28 Nov 2019-12-01

India Expo Centre,Greater Noida,Delhi NCR. Booth No:6L25,Warmly welcome to the booth.

2018 CPHI CHINA June 20-22, Shanghai New Intl Expo Centre 2018-04-09

CPhI China will open its gates again on 20 - 22 June 2018"CPhI China is a great way to tap into the market and connect with the potential suppliers from all over the world. Aside from networking with existing suppliers, it provides an opportunity to learn..

2017 CPHI India,Bombay Exhibition Centre, 28-30 Nov 2017-10-28

Taizhou Crene Biotechnology Co., Ltd. ATTEND THE CPHI INDIA 28-30 Nov 2017.Crene mainly produces pharmaceutical intermediates, such asIdelalisib intermediates 870281-86-0, Tedizolid intermediates 856866-72-3, Afatinib intermediates 314771-76-1, Ninteda..

CPHI Korea 22 - 24 JAugust 2017, COEX, Seoul, Korea. 2017-07-28

Manufactory for Rucaparib - Idelalisib-Palbociclib -Macitentan-Lenvatinib(E7080)-Olaparib-AZD9291-Afatinib intermediates， warmly welcome CPHI Korea 22 - 24 JAugust 2017, COEX, Seoul, Korea.Visit us at : F32

2017 CPHI CHINA June 20-22, Shanghai New Intl Expo Centre 2017-06-01

Taizhou Crene Biotechnology Co., Ltd.is specialized in the manufacture of APIs, pharmaceutical intermediates. Our company is located in the largest API base in China--Taizhou and Cooperated to established GMP standard production base and laboratory in surround..